Natasha Edwin

@JanakiramMurali @eaonc @VincentRK @myelomaMD @NorthTxMSG @nsc_natalie @JKaufmanMD @SagarLonialMD Always exciting to learn and have input in designing these excellent and impactful studies. Thanks to @eaonc for organizing this meeting!

Grt ECOG ACRIN MM meeting with many trial concepts presented, brainstormed @eaonc -new ideas -challenges in trial design -accrual challenges - met colleagues and exhchanged grt ideas @VincentRK @myelomaMD @NorthTxMSG @natashaedwin @nsc_natalie @JKaufmanMD @SagarLonialMD

@allisonoconn Very much a thing: especially in community practices in rural areas but also common in urban hospital employed settings. Used to be an off-ramp to retirement but increasingly seeing early and mid career docs choosing this path.

I recently found out locums oncologists is a thing? Crazy.

People often ask how breakthroughs occur in cancer biology-often the story is more complex - the survival plot for myeloma outcomes is extraordinary - improvements come about in incremental steps - in my lifetime treatment of Myeloma has almost transformed into a curable disease

Thank you, @natashaedwin @providence, for championing #cancer #clinicaltrial access for patients who live outside of academic research hubs. Why patients in rural areas need access to quality clinical trials: blog.providence.org/regional-blog-… #clinicalresearch

Join @ronanswords1 and @natashaedwin at #ORHemBreast26 in #Portland. Register now: binaytara.org/projects/confe… #MedTwitter #MedX #MedEd #HemeOnc #hematology #BreastCancer @OHSUKnight @ProvSwedish

@ramit I travel with 2-3 friends with diff diet/room preferences. We book private rooms in hostels and normalize splitting up for meals or side excursions a few times on the trip. Definitely calls for a great deal of flexibility, understanding and excellent communication!

My personal obsession is how people plan a friends’ trip where everyone has different preferences and amounts of money

Major goals of the @eaonc myeloma committee. We have an excellent team that works hard to design and conduct important clinical trials. @nsc_natalie @JanakiramMurali @MMBaljevicMD @MyelomaDrKapoor @natashaedwin @JKaufmanMD @myelomaMD @SagarLonialMD @NorthTxMSG @mtmdphd et al

Dr @VincentRK presenting at the Spring ECOG Conference in Tampa, FL and highlighting the Major Goals of the @eaonc Myeloma committee Prevent progression of smoldering multiple myeloma (SMM) to multiple myeloma (MM). Improve the treatment of newly diagnosed MM through an immunotherapy-based induction and maintenance. Improve outcomes for relapsed and refractory MM through early incorporation of bispecific antibodies and risk-adapted strategies. Develop MRD negativity and Myeloma-specific Patient Reporteo Outcome tools as endpoints for clinical trials. #mmsm

Thanks for the opportunity to participate @btfoundation @CLachowiez

It’s a pleasure and privilege to serve this group and represent community oncologists’ perspective. @JanakiramMurali

Elephants rare get cancer. Why? @MrinalPatnaik explains at the @eaonc meeting. They gave 40 copies of the p53 tumor suppressor gene. (Humans have 2 copies)

@EAonc is happy to jointly announce that the #myeloMATCH portfolio of precision medicine trials in #myeloid cancers is now open at 150 treatment sites across the US & Canada, & growing. #leukemia #myelodysplastic #leusm #MDSsm #bmtsm #AMLsm Press release: tinyurl.com/mMATCH-opens

Very cool history of the “Red Devil“and its link to U of O uniforms

Nothing beats a @WUHemeOncFellow accidental reunion at a conference! @natashaedwin

@AaronGoodman33 Would consider enrolling on EA4151 if feasible. ecog-acrin.org/clinical-trial…

Amid the grimness of life in oncology, it’s great to share stories of patients who do well! kptv.com/video/2024/06/…

ECOG-ACRIN Myeloma Core Committee - post meeting dinner - @eaonc @VincentRK @VincentRK @JanakiramMurali @SJ_OncBiostats @scmedlin @mtmdphd @MyelomaDrKapoor #mmsm #EAonc

@dgermain21 @joshuaafein The Nuance Dragon Ambient eXperience (DAX) is an AI powered scribe service that automatically documents patient encounters. I’m using it currently for hematology outpatients and definitely recommend!

@joshuaafein I worry we will encourage data to be pulled into notes that we truly didn’t review. Maybe inpatient documentation is a different beast?

Has any come up with an effective, safe, and hipaa-compliant way to use chatgpt to speed up their medical documentation? Not conceptually but actually doing so in practice? (Pseudonimized responses permitted…)

@INizMD @jeff_sharman I’ve been a hematologist (malignant and non malignant) in group of 8-10 MDs. As long as you have good support (clinic staff) and understanding among your partners (for hospital inpatient coverage): it’s very do-able even in smaller groups.

@jeff_sharman How common are jobs where you can see predominantly Hematology (malignant and non malignant)? I presume you would need to have a somewhat large group

Recent questions on "specialization" in community practice. I call it "regionalization." This week I see: CLL =28 pts Indolent NHL = 8 Aggressive lymphoma = 5 Myeloma = 8 Myeloid / benign heme = 10 Solid Tumor = 11 4d work week about 70 pts. I love the mix / diversity